Establishing Prospective Mediastinal Tumor Database of PUMCH
Launched by PEKING UNION MEDICAL COLLEGE HOSPITAL · May 14, 2024
Trial Information
Current as of February 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on collecting important information about patients with mediastinal tumors, which are growths found in the area of the chest between the lungs. The study will gather details like patient characteristics, imaging results, and other factors that can help doctors understand these tumors better. By creating a database at Peking Union Medical College Hospital, the researchers hope to improve how these tumors are diagnosed and treated.
If you or a loved one has been diagnosed with a mediastinal tumor and can provide written consent, you may be eligible to participate in this study. Participants will help contribute to a broader understanding of these conditions, which can ultimately lead to better medical care. It’s important to note that if there is incomplete clinical information about your diagnosis, you may not be able to take part in the trial. Overall, this study aims to support future treatment decisions and improve outcomes for patients with these types of tumors.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Clinical or pathological diagnosis of mediastinal tumors;
- • 2. Written consent is able to obtained.
- Exclusion Criteria:
- • 1. Incomplete clinicopathological information.
Trial Officials
Shanqing Li, Prof.
Study Chair
Peking Union Medical College Hospital
About Peking Union Medical College Hospital
Peking Union Medical College Hospital (PUMCH) is a prestigious medical institution and a leading research facility located in Beijing, China. Affiliated with the Chinese Academy of Medical Sciences, PUMCH is renowned for its commitment to advancing healthcare through innovative clinical research and high-quality patient care. The hospital plays a pivotal role in the development and execution of clinical trials across various medical disciplines, focusing on improving treatment outcomes and enhancing medical knowledge. With a multidisciplinary team of experts and state-of-the-art facilities, PUMCH is dedicated to contributing to global health advancements and fostering collaborations in the medical research community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, Beijing, China
Beijing, Beijing, China
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0